MPE comments on the Implementing Regulation on joint scientific consultations on medicinal products for human use at Union levelAccess, NewsOctober 29, 2024
MPE webinar on ASH 2024 myeloma and AL amyloidosis highlightsAL amyloidosis, MPE, Myeloma, NewsNovember 29, 2024
The European Commission grants final authorisation for belantamab mafodotin (Blenrep®) combinations for relapsed/refractory myeloma patientsMyeloma, NewsJuly 25, 2025
A second bispecific antibody is approved as a fourth-line treatment for myeloma in England and WalesAccess, Myeloma, NewsJuly 17, 2024
EMA CHMP gives positive opinion on isatuximab combination for newly diagnosed myeloma patientsAccess, Myeloma, NewsNovember 20, 2024
MPE provided feedback on the HTA Implementing Regulation on joint scientific consultations on medical devices and in vitro diagnostic medical devices at Union levelMPE, NewsNovember 27, 2024
New guidelines for the treatment and the management of myeloma and smouldering myelomaMyeloma, NewsJuly 14, 2025
EMA CHMP gives positive opinion on linvoseltamab for relapsed/refractory myeloma patientsAccess, Myeloma, NewsMarch 3, 2025
